Our name, Alimera, derives loosely from ancient Greek. Its intended meaning is “day of truth,”and it represents a company that stands for honesty, integrity, responsibility, candor and trust.We strive to be approachable. We emphasize responsiveness. We realize that there is no substitute for intelligence as we work toward discovering and delivering new products that add therapeutic value. And above all, we approach our relationships ethically, professionally and with a win-win mindset. To the benefit of end customers, healthcare professionals, our partners and our shareholders, these qualities shape the Alimera culture.
People
Dan Myers (President/CEO)
Susan Caballa (VP Regulatory & Medical Affairs)
Rick Eiswirth (CFO)
Ken Green (Chief Scientific Officer)
Dave Holland (VP Marketing)
News
Venrock showcases VC trend, raises small $350M fund
July 6, 2010 6:00 pm
Venrock, one of oldest and best known venture capital firms in Silicon Valley, has raised $350 million for its newest,… Continue reading 〉
Nicola Campbell, a 37-year old remarkable VC, passes away
June 10, 2008 5:59 pm
Nicola Campbell, venture capitalist with Sofinnova Ventures, who impressed me deeply with her ambition and intellect over the years I… Continue reading 〉
Life-science briefing: Tuesday, March 18, 2008
March 18, 2008 12:27 pm
TODAY’S HEADLINES: Luminous Medical raises $24M for automated glucose monitoring (release) Alimera Sciences gets $30M for eye-disease drug (release) Vaccine… Continue reading 〉
